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Abstract
Hemodialysis patients, due to a dysfunction of the immune response, are prone to a variety of
opportunistic infections. Studies of intestinal parasitic infections in these patients are limited.
Therefore, the present study was performed to determine the prevalence of these infections in
patients on hemodialysis in Bushehr. In this cross-sectional study, fecal samples have been collected
from all hemodialysis patients who were continuously referred from September 2011 to September
2012 to the dialysis center at Bushehr and tested using routine parasitological methods. From a
total of 88 patients studied, 25 patients (28.4%) were infected with one or more intestinal parasites.
Blastocystis hominis and Entamoeba coli with 13.6% and 6.7% prevalence had the highest preva-
lence among the patients, respectively. The age group 51–70 years had the highest rates of
infection. Statistical analysis showed no relationship between sex and the risk of intestinal para-
sites. Seventeen percent of infected patients showed up with diarrhea and this relationship was
statistically significant. Considering the high prevalence of intestinal parasitic infection among
hemodialysis patients in Bushehr and also the high probability of infection in these patients, it is
recommended that periodic examinations and screening patients during dialysis and before kidney
transplantation should be a part of routine medical care.
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INTRODUCTION
Despite continuous efforts and programs organized by the
World Health Organization (WHO), parasitic infections
are one of the obstacles to economic and social develop-
ment and a major health problem in most countries of the
world, particularly in developing countries.1,2
According to the statistics published by the WHO,
about 3 billion people worldwide are infected with para-
sitic infections.3 Although it is expected that because of
the high economic and health conditions in developed
countries, these infections are not much of importance,
but with the daily increase in the number of patients with
immune deficiency, increase organ transplant surgery and
chemical and immune-suppressing drugs and radiation
therapy, high statistics related to parasitic infection is not
unlikely.4,5
Compared with healthy people, patients with immune
suppressed systems are more vulnerable for parasitic
infections. Among these patients, a large group of organ
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transplant recipients, patients taking corticosteroid drugs
and chemotherapy, patients with cancer, acquired
immune deficiency syndrome (AIDS) patients, and people
undergoing radiation therapy as well as patients undergo-
ing hemodialysis can be pointed.6,7 With more than 95%
of kidney damage, accumulation of toxins in the body is
increased sufficiently and sustaining life would not be
possible without the use of dialysis or kidney transplant.8
Several reports indicate that populations with renal dys-
function requiring dialysis are rising.9 The number of
hemodialysis patients has doubled since 1990.9 According
to America’s renal information, approximately 90% of
patients with chronic renal failure are on hemodialysis.10
The number of patients with kidney complications is
increasing significantly time by time. For instance, the
number of those patients increased from 14000 in 2007 to
22000 in 2010.9,10
Patients with chronic renal failure who are undergoing
hemodialysis because of dysfunction and decreased lym-
phocytes, dysfunction of the complement system and
immune responses, including chemotaxis and phagocyto-
sis, have a high probability of suffering from a variety of
opportunistic viral and parasitic infections.11–13 In a study
in hemodialysis patients in Isfahan, Iran, the prevalence of
intestinal parasitic infections was at 23.9%; the highest
infection rate was in persons 51–65 years old with 29.7%
incidence. There was a significant relationship between
prevalence and age, duration of dialysis, and health status
of people in that study.5
Considering that the prevalence of intestinal parasitic
infections has a high percentage in dialysis patients, it is
necessary that doctors and nephrologists should clinically
test these patients for intestinal parasitic infections before
medication drugs. However, in patients with immune
deficiency, due to a decrease in white blood cells, common
signs and symptoms of infection such as fever withheld
and diagnosis of infection in these patients is difficult;
therefore, it seems that identification of parasitic infec-
tions relying on special parasitology methods is necessary
in these groups.14 Given that few studies have been per-
formed in this regard in Iran, the present study was con-
ducted to determine the prevalence of intestinal parasitic
infections in hemodialysis patients in southwest of Iran,
Bushehr.
MATERIALS AND METHODS
This study was confirmed by Bushehr University of
Medical Sciences with ethic number: 20.71.7170.
In this cross-sectional study, all the hemodialysis
patients in Bushehr were studies because there is just one
center for those patients in Bushehr and we had access to
all of them in period of September 2011 till September
2012.
After getting permission to conduct research and coor-
dination between the authorities, records were lookup
at the hospital dialysis center and through interviews
and questionnaires were completed. Questionnaire was
designed on demographic information as well as impor-
tant factors and variables involved in this study. Stool
sample container was delivered to each of the subjects.
The next day the samples were collected in standard
condition transferred to the parasitology laboratory at
Bushehr University of Medical Sciences. All samples were
tested using direct smear (wet mount and lugol) and, also,
to increase the accuracy of the test, the formalin-ether
concentration method were used according to the proto-
col recommended by the WHO. Test results with data
from the questionnaires were analyzed using SPSS soft-
ware version 18 (SPSS Inc., Chicago, IL, USA; version 18).
RESULTS
In this cross-sectional study, all patients undergoing
hemodialysis in Bushehr, Iran, were studied for a year.
From a total of 88 patients studied, 25 patients (28.4%)
were infected with one or more intestinal parasites. Blas-
tocystis hominis with 13.6% and then Entamoeba coli with
6.7% prevalence had the highest prevalence among the
patients, respectively. Of the total cases, 21 cases (23.9%)
were infected with only one species of parasite and four
people (4.5%) with more than one parasite species.
Results of the prevalence of intestinal parasites in hemo-
dialysis patients are given in Table 1 according to the type
of parasites.
Table 2 shows the prevalence of intestinal parasites by
age and, as implied, the age group 51–70 years had the
Table 1 Distribution of intestinal parasites in hemodialysis
patients in Bushehr
Parasite Frequency Percentage
Blastocystis hominis 8 9
Entamoeba coli 6 6.7
Giardia lamblia 3 3.4
Endolimax nana 2 2.3
Iodamoeba bütchlii 1 1.2
Taenia saginata 1 1.2
Mixed infection 4 4.6
Noninfection 63 71.6
Total 88 100
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highest rates of infection. However, no significant corre-
lation was found between the incidence of intestinal para-
sites and age (Table 2).
Forty-six of the patients (52.3%) were male and others
(47.7%) were female. Statistical analysis showed no rela-
tionship between sex and the risk of infection with intes-
tinal parasites. In Table 3, the prevalence of intestinal
parasites in hemodialysis patients is noted by sex.
Sixty-three of the patients studied (71.6%) were urban
dwellers and 25 patients (28.4%) were from rural areas. In
terms of education levels, patients were divided into three
groups: no education (45.5%), low education (36.4%)
and secondary education (18.2%). Some other variables
such as job, history of contact with animals, clinical symp-
toms as abdominal pain, appetite, nausea, vomiting, diar-
rhea and weight loss, and allergies were also analyzed. The
tests revealed no significant differences between parasitic
infection and abdominal pain, although a significant
number of hemodialysis patients infected with intestinal
parasites also had abdominal pain at the same time in
comparison with those who were not infected (P
value = 0.05). Also, 17% of infected patients have diar-
rhea and this association was statistically significant (P
value < 0.03) (Table 4).
DISCUSSION
Immunocompromised patients are more vulnerable to
parasitic infections.5 Patients with chronic renal failure
who are on hemodialysis, resulting in dysfunction of the
immune response, are also prone to a variety of opportu-
nistic infections.5,11 Many studies have been conducted on
the prevalence of intestinal parasitic infections in immu-
nocompromised patients, especially in AIDS patients;
however, in patients who are undergoing dialysis regularly
because of chronic kidney failure, these studies are
limited.15–17 In these patients the typical non-specific
symptoms, such as fever might not be seen due to the
decreased number of white blood cells. Therefore, diag-
nosis can be difficult; therefore, performing conventional
parasitological methods to detect the parasitic infections
in this group of patients are crucial.14 In the present study,
the prevalence of intestinal parasites was achieved at
28.4% which is rather remarkable and, because of the
specific population, has potential importance. This result
has similarity with some studies carried out in other
places; in a study conducted in dialysis patients in
Isfahan in 2008, the incidence was reported at 23.9%, the
Table 2 Distribution of intestinal parasites in hemodialysis
patients by age
Age
Result
Total
Negative Positive
N % N %
≤30 12 13.6 1 1.1 13 14.8
31–50 16 18.2 7 8 23 26.1
51–70 25 28.4 14 15.9 39 44.3
>71 10 11.4 3 3.4 13 14.8
Total 63 71.6 25 28.4 88 100
Table 3 Distribution of intestinal parasites in hemodialysis
patients by sex
Sex
Result
TotalNegative Positive
N % N % N %
Male 32 36.4 14 15.9 46 52.3
Female 31 35.2 11 12.5 42 47.7
Total 63 71.6 25 28.4 88 100
Table 4 Distribution of intestinal parasites in hemodialysis
patients by some effective factors
Variables
Prevalence
P value
Positive Negative
n % n %
Residence
City 17 19.3 46 52.3 0.42
Village 8 9.1 17 19.3
Education level
Illiterate 15 17 25 28.4
Low literacy 7 8 25 28.4 0.10
Educated 3 3.4 13 14.8
Abdominal pain
Yes 12 13.6 17 19.3 0.05
No 13 14.8 46 52.3
Appetite
Yes 5 5.7 21 24.1 0.16
No 19 21.8 42 48.3
Nausea
Yes 12 13.8 29 33.3 0.60
No 12 13.8 34 39.1
Diarrhea
Yes 15 17 19 21.6 <0.03
No 10 11.4 44 50
Lose weight
Yes 12 13.6 22 25 0.18
No 13 14.8 41 46.6
Itch
Yes 9 10.3 32 36.8 0.19
No 15 17.2 31 35.6
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researcher has suggested clinical tests for these patients
before prescribing medicine and also pretransplant as a
care program.5 In another study in 2000 that was con-
ducted on cancer patients receiving chemotherapy, 34% of
them were infected with intestinal parasites and fecal spe-
cific tests is mentioned as the basic measures to reduce
such infections before starting and during chemo-
therapy.18 The reported prevalence of intestinal parasites
in immunosuppressed patients in Tehran, which was per-
formed in 1998, was at 34.5%.4 Some studies have
reported a higher and lower prevalence than in this study;
in a study on dialysis patients, 45.1% of them were
infected with various types of intestinal parasites, the
authors suggest that routine parasitology tests should be
included in these groups.19 On the other hand, some
studies have reported a lower incidence than expected; in
a study in patients with malignancy in Hamedan, 16%
prevalence was achieved and the main reason for the low
incidence in these patients compared with its prevalence
in the region is expressed because of the effects of the
drugs used in chemotherapy.20 It seems that observed
differences in outcomes are due to differences in study
population, study duration, climatic conditions, customs,
and culture and dietary habits.
In the present study, B. hominis was the most common
intestinal parasite as an opportunistic pathogen and it
was also the same parasite reported as most common in
some other studies on dialysis or immunosuppressed
patients.4,18,19,21 Blastocystis hominis is an opportunistic
parasite and according to many researchers’ recommenda-
tions, if the infection is accompanied with clinical symp-
toms and these symptoms cannot be explained by other
factors, it seems medical therapy is necessary in these
cases.4,18 In this review, E. coli was identified as the second
most common parasite with 6.7% prevalence. Although
E. coli is a nonpathogenic parasite, however, the high
prevalence of this parasite is important as an indicator for
poor health, especially in terms of water and food con-
tamination that should be considered.22 In this study,
Giardia lamblia is a third common parasite. This parasite is
a pathogen and it can be the cause of many gastrointesti-
nal disorders and dyspepsia.23 Two nonpathogenic proto-
zoan Endolimax nana and Iodamoeba bütchlii are the next in
ranks and as E. coli indicate the lack of proper health
standards. In this research, protozoan infection rate was
much higher than helminthes and the only worm infec-
tion reported is Taenia saginata. Undoubtedly, some health
appropriate measures, such as not using human feces as
fertilizer on farms, and health education can be logical
justification for reducing the types of worm infections and
recent statistics indicate this fact. Although in the present
study, statistical analysis did not show a significant rela-
tionship between infection with level of education, age,
and sex, infection rate in the age group 51–70 years was
higher than other age groups. In some similar studies, the
highest prevalence was reported in the age group above 50
years.5,18,20 In a study, infection rates in urban areas is
mentioned higher than in rural areas and the author has
described that it is because population is higher in urban
areas compared with rural areas.5 In the present study,
there was no relationship between the prevalence of infec-
tion and residence.
Another variable evaluated in this study includes the
relationship between infection and gastrointestinal symp-
toms, such as some abdominal pain, nausea, diarrhea,
appetite, weight loss, and pruritus. Statistical analysis
showed that there was a significant relationship between
the infection and diarrhea. In a similar study, the highest
prevalence of infection was detected in patients with diar-
rhea, but this relationship was not significant.5 Of the
limitations of this study, the absence of a control group
with the experimental group can be noted, which was not
possible because of financial restrictions, and it seems that
this issue could be due to the lack of significant relation-
ship between infection and some symptoms.
Considering the high prevalence of intestinal parasitic
infection among hemodialysis patients in Bushehr, Iran,
and also considering the fact that the immune system of
these patients has less efficiency to deal with opportunistic
infections compared with healthy subjects, it is recom-
mended that periodic examinations and screening
patients during dialysis and before kidney transplantation
should be a part of routine medical care.
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